title: Topoisomerase II expression in osseous tissue.
abstract: The molecular mechanisms that mediate the transition from an osteoprogenitor cell to a differentiated osteoblast are unknown. We propose that topoisomerase II (topo II) enzymes, nuclear proteins that mediate DNA topology, contribute to coordinating the loss of osteoprogenitor proliferative capacity with the onset of differentiation. The isoforms topo II-alpha and -beta, are differentially expressed in nonosseous tissues. Topo II-alpha expression is cell cycle-dependent and upregulated during mitogenesis. Topo II-beta is expressed throughout the cell cycle and upregulated when cells have plateaued in growth. To determine whether topo II-alpha and -beta are expressed in normal bone, we analyzed rat lumbar vertebrae using immunohistochemical staining. In the tissue sections, topo II-alpha was expressed in the marrow cavity of the primary spongiosa. Mature osteoblasts along the trabecular surfaces did not express topo II-alpha, but were immunopositive for topo II-beta, as were cells of the marrow cavity. Confocal laser scanning microscopy was used to determine the nuclear distribution of topo II in rat osteoblasts isolated from the metaphyseal distal femur and the rat osteosarcoma cells, ROS 17/2.8. Topo II-alpha exhibited a punctate nuclear distribution in the bone cells. Topo II-beta was dispersed throughout the interior of the nucleus but concentrated at the nuclear envelope. Serum starvation of the cells attenuated topo II-alpha expression but did not modulate expression of the beta-isoform. These results indicate that the loss of osteogenic proliferation correlates with the downregulation of topo II-alpha expression.
authors.affiliation: Department of Anatomy, Indiana University School of Medicine, Indianapolis 46202, USA.
authors.forename: H A
authors.initials: HA
authors.lastname: Feister
authors.forename: D
authors.initials: D
authors.lastname: Swartz
authors.forename: P R
authors.initials: PR
authors.lastname: Odgren
authors.forename: J
authors.initials: J
authors.lastname: Holden
authors.forename: J M
authors.initials: JM
authors.lastname: Hock
authors.forename: J
authors.initials: J
authors.lastname: Onyia
authors.forename: J P
authors.initials: JP
authors.lastname: Bidwell
mesh_terms: D000818:Animals; D001854:Bone Marrow Cells / Q000201:enzymology; D002467:Cell Nucleus / Q000201:enzymology; D002478:Cells, Cultured; D016895:Culture Media, Serum-Free; D004250:DNA Topoisomerases, Type II / Q000096:biosynthesis*; D015971:Gene Expression Regulation, Enzymologic; D006132:Growth Plate / Q000201:enzymology; D007527:Isoenzymes / Q000096:biosynthesis*; D008159:Lumbar Vertebrae / Q000201:enzymology; D008297:Male; D018613:Microscopy, Confocal; D010006:Osteoblasts / Q000166:cytology / Q000201:enzymology*; D012516:Osteosarcoma / Q000201:enzymology*; D051381:Rats; D014407:Tumor Cells, Cultured
chemical_list: D016895:Culture Media, Serum-Free; D007527:Isoenzymes; D004250:DNA Topoisomerases, Type II